EcoDrugPlus

Ensembl ID : ENSOTSG00005043136
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOTSG00005041413
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOTSG00005002208
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSOTSG00005002820
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOTSG00005003582
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSOTSG00005041833
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSOTSG00005003585
Gene Symbol: VDRB
1 Cross references
385 Possible Orthologues:

Ensembl ID : ENSOTSG00005041987
Gene Symbol: PSEN2
1 Cross references
199 Possible Orthologues:

Ensembl ID : ENSOTSG00005042001
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSOTSG00005037931
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSOTSG00005035212
Gene Symbol: RPL18A
1 Cross references
363 Possible Orthologues:

Ensembl ID : ENSOTSG00005042042
Gene Symbol: THRB
1 Cross references
386 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).